Compare Medpace Holdings Inc (MEDP) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Waste Management, Inc. — how do they compare? Medpace Holdings Inc trades at $530.31 (market cap $15.08B), while Waste Management, Inc. trades at $234.42 (market cap $96.00B). The key difference: Waste Management, Inc. is far larger — about 6.4× Medpace Holdings Inc's market cap, and Waste Management, Inc. pays a 1.48% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | WM | |
|---|---|---|
Market Cap | $15.08B | $96.00B |
Sector | Technology | Industrials |
52-Week High | $620.59 | $246.51 |
52-Week Low | $308.88 | $196.77 |
Enterprise Value | $14.55B | $118.73B |
Dividend Yield | — | 1.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
WM trades at $239.26, showing minimal daily movement with a slight 0.02% decline. The stock maintains a bullish technical outlook with strong moving average signals and trades near its pivot point of $241. Fundamentally, the company demonstrates solid revenue growth from $19.7B in 2022 to $25.2B in 2025, though recent quarters show mixed earnings performance with two misses and one beat against expectations.
WM presents a stable investment case with consistent dividend payments and strong analyst support (57% buy ratings), but faces challenges from elevated debt levels and valuation multiples. The consensus price target of $263.57 suggests 10% upside potential, though investors should monitor execution on earnings guidance and debt management in the coming quarters.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
